Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Specialty Active Pharmaceutical Ingredients Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Specialty Active Pharmaceutical Ingredients Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Specialty Active Pharmaceutical Ingredients Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type
    • 1.4.2 Steroidal API
    • 1.4.3 Peptide API
    • 1.4.4 Carbohydrate API
    • 1.4.5 Small Molecule API
    • 1.4.6 High Potency AP
  • 1.5 Market by Application
    • 1.5.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application
    • 1.5.2 CNS
    • 1.5.3 Cardiovascular
    • 1.5.4 Genitourinary/Hormonal Drugs
    • 1.5.5 Rheumatology
    • 1.5.6 Diabetes
    • 1.5.7 Oncology
    • 1.5.8 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Specialty Active Pharmaceutical Ingredients Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Specialty Active Pharmaceutical Ingredients Industry
      • 1.6.1.1 Specialty Active Pharmaceutical Ingredients Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Specialty Active Pharmaceutical Ingredients Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Specialty Active Pharmaceutical Ingredients Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Specialty Active Pharmaceutical Ingredients Market Size Estimates and Forecasts
    • 2.1.1 Global Specialty Active Pharmaceutical Ingredients Revenue 2015-2026
    • 2.1.2 Global Specialty Active Pharmaceutical Ingredients Sales 2015-2026
  • 2.2 Specialty Active Pharmaceutical Ingredients Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Specialty Active Pharmaceutical Ingredients Competitor Landscape by Players

  • 3.1 Specialty Active Pharmaceutical Ingredients Sales by Manufacturers
    • 3.1.1 Specialty Active Pharmaceutical Ingredients Sales by Manufacturers (2015-2020)
    • 3.1.2 Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers
    • 3.2.1 Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2015-2020)
    • 3.2.2 Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Specialty Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Specialty Active Pharmaceutical Ingredients Revenue in 2019
    • 3.2.5 Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Specialty Active Pharmaceutical Ingredients Price by Manufacturers
  • 3.4 Specialty Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
    • 3.4.1 Specialty Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Specialty Active Pharmaceutical Ingredients Product Type
    • 3.4.3 Date of International Manufacturers Enter into Specialty Active Pharmaceutical Ingredients Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Type (2015-2020)
    • 4.1.1 Global Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020)
    • 4.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2015-2020)
    • 4.1.3 Specialty Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Specialty Active Pharmaceutical Ingredients Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Type (2021-2026)
    • 4.2.3 Specialty Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Specialty Active Pharmaceutical Ingredients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Application (2015-2020)
    • 5.1.1 Global Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020)
    • 5.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2015-2020)
    • 5.1.3 Specialty Active Pharmaceutical Ingredients Price by Application (2015-2020)
  • 5.2 Specialty Active Pharmaceutical Ingredients Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Specialty Active Pharmaceutical Ingredients by Country
    • 6.1.1 North America Specialty Active Pharmaceutical Ingredients Sales by Country
    • 6.1.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
  • 6.3 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Specialty Active Pharmaceutical Ingredients by Country
    • 7.1.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Country
    • 7.1.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
  • 7.3 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Specialty Active Pharmaceutical Ingredients by Region
    • 8.1.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region
    • 8.1.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
  • 8.3 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Specialty Active Pharmaceutical Ingredients by Country
    • 9.1.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country
    • 9.1.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
  • 9.3 Central & South America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients by Country
    • 10.1.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country
    • 10.1.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
  • 10.3 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.1.5 Sanofi Recent Development
  • 11.2 Cambrex
    • 11.2.1 Cambrex Corporation Information
    • 11.2.2 Cambrex Description, Business Overview and Total Revenue
    • 11.2.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Cambrex Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.2.5 Cambrex Recent Development
  • 11.3 Almac
    • 11.3.1 Almac Corporation Information
    • 11.3.2 Almac Description, Business Overview and Total Revenue
    • 11.3.3 Almac Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Almac Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.3.5 Almac Recent Development
  • 11.4 Johnson Matthey
    • 11.4.1 Johnson Matthey Corporation Information
    • 11.4.2 Johnson Matthey Description, Business Overview and Total Revenue
    • 11.4.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Johnson Matthey Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.4.5 Johnson Matthey Recent Development
  • 11.5 PolyPeptide
    • 11.5.1 PolyPeptide Corporation Information
    • 11.5.2 PolyPeptide Description, Business Overview and Total Revenue
    • 11.5.3 PolyPeptide Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 PolyPeptide Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.5.5 PolyPeptide Recent Development
  • 11.6 AmbioPharm
    • 11.6.1 AmbioPharm Corporation Information
    • 11.6.2 AmbioPharm Description, Business Overview and Total Revenue
    • 11.6.3 AmbioPharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 AmbioPharm Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.6.5 AmbioPharm Recent Development
  • 11.7 Avecia
    • 11.7.1 Avecia Corporation Information
    • 11.7.2 Avecia Description, Business Overview and Total Revenue
    • 11.7.3 Avecia Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Avecia Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.7.5 Avecia Recent Development
  • 11.8 ST Pharm
    • 11.8.1 ST Pharm Corporation Information
    • 11.8.2 ST Pharm Description, Business Overview and Total Revenue
    • 11.8.3 ST Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 ST Pharm Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.8.5 ST Pharm Recent Development
  • 11.9 Biospring
    • 11.9.1 Biospring Corporation Information
    • 11.9.2 Biospring Description, Business Overview and Total Revenue
    • 11.9.3 Biospring Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Biospring Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.9.5 Biospring Recent Development
  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Products Offered
    • 11.1.5 Sanofi Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Region
    • 12.1.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Regions 2021-2026
  • 12.2 North America Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
    • 12.2.1 North America: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
    • 12.2.2 North America: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
    • 12.2.3 North America: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
    • 12.3.2 Europe: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Specialty Active Pharmaceutical Ingredients Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Specialty Active Pharmaceutical Ingredients Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Specialty Active Pharmaceutical Ingredients market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Specialty Active Pharmaceutical Ingredients market is segmented into
    Steroidal API
    Peptide API
    Carbohydrate API
    Small Molecule API
    High Potency AP

    Segment by Application, the Specialty Active Pharmaceutical Ingredients market is segmented into
    CNS
    Cardiovascular
    Genitourinary/Hormonal Drugs
    Rheumatology
    Diabetes
    Oncology
    Others

    Regional and Country-level Analysis
    The Specialty Active Pharmaceutical Ingredients market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Specialty Active Pharmaceutical Ingredients market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Specialty Active Pharmaceutical Ingredients Market Share Analysis
    Specialty Active Pharmaceutical Ingredients market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Specialty Active Pharmaceutical Ingredients business, the date to enter into the Specialty Active Pharmaceutical Ingredients market, Specialty Active Pharmaceutical Ingredients product introduction, recent developments, etc.
    The major vendors covered:
    Sanofi
    Cambrex
    Almac
    Johnson Matthey
    PolyPeptide
    AmbioPharm
    Avecia
    ST Pharm
    Biospring

    Buy now